E. Felip

Discipline

Psychologie (2) Economies et finances (1)

Type de document

Articles (10) Recensions (7)

Co-auteur

Date

Source

Mot-clé

Treatment (9) Lungs--Cancer (9) Diagnosis (6) Diagnosis (6) maladie (5) temps (durée) (4) maladie (4) Time (4) Human beings (4) Lungs (4) Cancer (4) Practice (4) tumeur (3) recommandation (3) pathologie (3) papier (3) oncologie (3) Lugano (3) Complement (3) Chemotherapy (3) Congresses (3) Specialists (3) Theater (3) Patients (3) Pathology (3) Paper (3) Oncology (3) Meetings (3) Forums (Discussion and debate) (3) Evidence (3)

Documents écrit par E. Felip (10) | parle de E. Felip (0)

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey.
P. Garrido et al.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
M.C. Garassino et al.
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.
A. Passaro et al.
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
D.P. Carbone et al. (22 juin 2017)
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
W.E. Eberhardt et al. (2015)
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease.
B. Besse et al. (2014)
Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up : 2nd ESMO Consensus Conference on Lung Cancer.
J. Vansteenkiste et al. (2014)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
J. Vansteenkiste et al. (2013)
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
M. Früh et al. (2013)
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
S. Peters et al. (2012)